Clinical Trial Update: Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study by Novo Nordisk comparing a current and a new biphasic insulin aspart 30 formulation in healthy volunteers to evaluate pharmacokinetics and safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• biphasic insulin aspart 30 formulation (current vs new) (insulin aspart protamine suspension with insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED